Alzheimer's disease

Merck terminates Phase II trials for Alzheimer’s drug due to liver toxicity
Clinical Trials Arena
Thu, 10/26/23 - 11:53 am
Merck
clinical trials
MK-1942
liver toxicity
Alzheimer's disease
Eisai says new data could support more convenient form of Alzheimer’s drug Leqembi
BioPharma Dive
Wed, 10/25/23 - 10:42 pm
Eisai
Biogen
Leqembi
Alzheimer's disease
Araclon vaccine appears to slow Alzheimer's in exploratory phase 2 analysis, spurring review of next steps
Fierce Biotech
Wed, 10/25/23 - 09:56 am
Araclon
Grifols
Alzheimer's disease
clinical trials
vaccines
ABvac40
CuraSen to bring new Alzheimer’s drug into trial in 2024
Clinical Trials Arena
Wed, 10/18/23 - 10:05 am
CuraSen Therapeutics
clinical trials
CST-3056
Alzheimer's disease
As 'harvest time' arrives for Alzheimer's, neuroscientist reflects on next steps for drug development
Fierce Biotech
Mon, 10/16/23 - 10:12 am
Alzheimer's disease
Biogen
Eisai
Eli Lilly
Leqembi
donanemab
Biogen's Aduhelm headache returns as appeals court revives part of investor lawsuit
Fierce Pharma
Thu, 10/12/23 - 05:18 pm
Biogen
Aduhelm
legal
Eisai
Alzheimer's disease
Labcorp launches 3-part blood test for Alzheimer's
Reuters
Wed, 10/11/23 - 10:02 am
LabCorp
Medtech
diagnostics
biomarkers
Alzheimer's disease
Novartis-backed AstronauTx heads off for Alzheimer's mission with $61M series A
Fierce Biotech
Mon, 10/9/23 - 11:12 am
AstronauTx
Novartis
Alzheimer's disease
Longeveron's Alzheimer's Candidate Meets Safety Goal In Mid-Stage Study
Benzinga
Fri, 10/6/23 - 11:45 am
Longeveron
clinical trials
Alzheimer's disease
lomacel-B
Roche pays Ionis $60M upfront to license RNA-targeting Alzheimer's, Huntington's programs
Fierce Biotech
Wed, 09/27/23 - 10:14 am
Roche
Ionis Pharmaceuticals
RNA
Alzheimer's disease
Huntington's disease
Japan approves Alzheimer's treatment Leqembi by Eisai and Biogen
Reuters
Tue, 09/26/23 - 10:23 am
Biogen
Eisai
Japan
Leqembi
Alzheimer's disease
Cassava Sciences Announces Positive Interim Safety Review of Simufilam On-going Phase 3 Trials in Patients with Alzheimer’s Disease
BioSpace
Mon, 09/18/23 - 07:45 pm
Cassava Sciences
clinical trials
Simulfilam
Alzheimer's disease
Anavex’s Blarcamesine Slows Cognitive Decline in Alzheimer’s Patients
BioSpace
Fri, 09/15/23 - 11:41 am
Anavex
Alzheimer's disease
blarcamesine
clinical trials
The Alzheimer’s Treatment Landscape: Leqembi vs. Donanemab
BioSpace
Mon, 09/11/23 - 12:34 pm
Alzheimer's disease
Eli Lilly
Biogen
Eisai
Leqembi
donanemab
Competing in These 3 Markets Could Send Eli Lilly Stock Soaring
Motley Fool
Tue, 09/5/23 - 11:23 am
Eli Lilly
Alzheimer's disease
obesity
painkillers
Vaxxinity Alzheimer’s treatment shows promising results in early trial
Biopharma Reporter
Tue, 08/15/23 - 10:07 am
Vaxxinity
clinical trials
UB-311
Alzheimer's disease
New Alzheimer’s drug raises hopes — along with questions
Medical Marketing and Media
Mon, 08/14/23 - 06:54 pm
FDA
Alzheimer's disease
Eisai
Biogen
Leqembi
More Alzheimer's Treatments Are Coming: This Company Can Help With Early Detection
Motley Fool
Thu, 08/10/23 - 11:39 am
Alzheimer's disease
diagnostics
Quest Diagnostics
Takeda, Denali drop Alzheimer's asset after phase 1 peak reveals 'narrow therapeutic window'
Fierce Biotech
Wed, 08/9/23 - 11:56 am
Takeda
Denali Therapeutics
Alzheimer's disease
clinical trials
The real costs of the new Alzheimer’s drug, most of which will fall to taxpayers
Medical Marketing and Media
Wed, 08/2/23 - 10:43 pm
Eisai
Biogen
Leqembi
Alzheimer's disease

Pages